Janet Hopkins
Technik-/Wissenschafts-/F&E-Leiter bei AURA BIOSCIENCES, INC.
Vermögen: 1 Mio $ am 30.04.2024
Aktive Positionen von Janet Hopkins
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Direktor/Vorstandsmitglied | 17.02.2022 | - |
| AURA BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 16.10.2023 | - |
Karriereverlauf von Janet Hopkins
Ehemalige bekannte Positionen von Janet Hopkins
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 01.11.2021 | 01.10.2023 |
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Vorstandsvorsitzender | 01.12.2021 | 01.10.2023 |
Ausbildung von Janet Hopkins
| McMaster University | Doctorate Degree |
Statistik
International
| Vereinigtes Königreich | 3 |
| Vereinigte Staaten | 2 |
| Schweiz | 2 |
Operativ
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AURA BIOSCIENCES, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Gyroscope Therapeutics Holdings Plc engages in the development of gene therapy beyond rare diseases. It focuses on age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Janet Hopkins
- Erfahrung
